期刊文献+

莪术中姜黄素在大鼠体内的药动学研究 被引量:7

Pharmacokinetic studies on curcumin in Curcuma phaeocaulis in rats in vivo
下载PDF
导出
摘要 目的研究莪术中姜黄素在大鼠体内的药动学.方法采用高效液相色谱法测定姜黄素的血药浓度.色谱柱:Lichrospher-5-C18(250 mm×4.6 mm,5 μm);柱温:25℃;流动相:乙腈-5%醋酸水(45:55);体积流量:1 mL/min;检测波长:420 nm.结果姜黄素在6.5~104 μg/mL与峰面积呈良好的线性关系(r=0.999 5).平均回收率为98.5%,RSD为2.41%(n=5).采用药动学计算程序处理,姜黄素的药动学参数:ka为0.53/h、ke为0.10/h、t1/2ka为1.32 h、t1/2k为6.89 h、tpeak为3.89 h、Cmax为93.15 ng/mL、AUC为1 369.38 ng/mL.结论本法稳定、简单、可靠,可用于姜黄素的血药浓度分析及其药动学研究. Objective To study pharmacokinetics of curcumin in Curcuma phaeocaulis in rats in vivo. Methods HPLC method was used to determine the curcumin in rat plasma. The conditions were column; Lichrospher-5-C18 (250 mm × 4.6 mm, 5 μm) ; column temperature: 25 C ; mobile phase: CH3CN-5% HAc water solution (45 : 55); flow: 1 mL/min; detection wavelength: 420 nm. Results The calibration curve was liner (r=0. 999 5) at the range of 6.5-104 μg/mL. The average recovery was 98.5%. RSD was 2.41% (n=5). The pharmacokinetic parameters of curcumin were as follows: ka was 0.53/h, ke was 0. 10/h, t1/2ka was 1. 32 h, t1/2k was 6. 89 h, tpeak was 3. 89 h, Cmax was 93.15 ng/mL, AUC was 1 369.38 ng/mL. Conclusion This method is stable, simple, and reliable, which can be applied for the determination of curcumin in plasma and oharmacokinetic studies.
机构地区 南京中医药大学
出处 《中草药》 CAS CSCD 北大核心 2005年第8期1157-1158,共2页 Chinese Traditional and Herbal Drugs
基金 国家"十五"攻关课题(2001BA701A11)
关键词 莪术 姜黄素 药动学 高效液相色谱 血药浓度 Curcuma phaeocaulis Val. curcumin pharmacokinetics HPLC
  • 相关文献

参考文献3

  • 1SuCY LiuJY XuHX etal.The metabolism of 3Hcurcumol in normal rats and tumour bearing mice [J].药学学报,1980,15(5):257-262.
  • 2HanT MiHM.Advances in research of chemical constituents and pharmacological activities of curcumin [J].解放军药学学报,2001,17(2):95-97.
  • 3刘同征,钱之玉.西红花酸在大鼠的药代动力学研究[J].药学学报,2002,37(5):367-369. 被引量:10

二级参考文献7

  • 1Xu GJ. Pharmacognosy (生药学) [M]. Beijing: People's Medical Publishing House, 1988.422-423.
  • 2Gao WY, Zhu DY. Reviews of Crocus sativus L ingredients and related pharmacology [J]. Chin Tradit Herb Drugs (中草药), 1999,30(5):389-391.
  • 3Wang CJ, Chang MC, Lin JK. Inhibition of growth and development of the transplantable C-6 glioma cells inoculated in rats by retinoids and carotenoids [J]. Cancer Lett, 1989,48(3):135-139.
  • 4Wang CJ, Chang MC, Lin JK. Inhibition of tumor promotion in benzo[α]pyrene-initiated CD-1 mouse skin by crocetin [J]. Carcinogenesis, 1995,16(2):187-191.
  • 5Nair SC, Panikkar KR. Protective effects of crocetin on the bladder toxicity induced by cyclophosphamide [J]. Cancer Biother, 1993,8(4):339-342.
  • 6Tseng TH, Chu CY, Huang JM, et al. Crocetin protects against oxidative damage in rat primary hepatocyte [J]. Cancer Lett, 1995,97(4):61-67.
  • 7Wang CJ, Shiow SJ, Lin JK. Effects of crocetin on the hepatotoxicity and hepatic DNA binding of aflatoxin B1 in rats [J]. Carcinogenesis, 1991,12(3):459-465.

共引文献9

同被引文献102

引证文献7

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部